Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first) - A prospective multicenter phase IIA study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2018
At a glance
- Drugs Everolimus (Primary) ; Prednisone (Primary) ; Prednisone (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms PredEver first
- 18 Apr 2018 Planned End Date changed from 31 Jan 2018 to 1 Jun 2018.
- 04 Apr 2018 This trial has been completed in Germany, according to European Clinical Trials Database (on-2018-02-07) record.
- 07 May 2017 Planned End Date changed from 1 Jul 2017 to 31 Jan 2018.